OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury
José Lillo‐Moya, Catalina Rojas-Solé, Diego Muñoz-Salamanca, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 667-667
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Ferroptosis: Opportunities and Challenges in Myocardial Ischemia‐Reperfusion Injury
Weikun Zhao, Yao Zhou, Tongtong Xu, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 138

Insight into Crosstalk between Ferroptosis and Necroptosis: Novel Therapeutics in Ischemic Stroke
Yue Zhou, Jun Liao, Zhigang Mei, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 113

Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis
Mingyue Tan, Yunfei Yin, Xiao Ma, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 92

Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition
Weixiang Chen, Yue Zhang, Zuoxiang Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 72

Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential
Xv-shen Ding, Li Gao, Han Zheng, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102077-102077
Closed Access | Times Cited: 67

The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 59

Deubiquitinase OTUD5 as a Novel Protector against 4‐HNE‐Triggered Ferroptosis in Myocardial Ischemia/Reperfusion Injury
Lulu Liu, Jiaojiao Pang, Dandan Qin, et al.
Advanced Science (2023) Vol. 10, Iss. 28
Open Access | Times Cited: 49

Sleep fragmentation exacerbates myocardial ischemia‒reperfusion injury by promoting copper overload in cardiomyocytes
Na Chen, Lizhe Guo, Lu Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22

The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury
Shuo Zhang, Fei Yan, Fei Luan, et al.
Phytomedicine (2024) Vol. 129, pp. 155649-155649
Closed Access | Times Cited: 17

Targeting Ferroptosis by Polydopamine Nanoparticles Protects Heart against Ischemia/Reperfusion Injury
Yabing Zhang, Xiangyi Ren, Yan Wang, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 45, pp. 53671-53682
Closed Access | Times Cited: 97

Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury
Yihang Pan, Xueke Wang, Xiwang Liu, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2196-2196
Open Access | Times Cited: 65

Britanin relieves ferroptosis-mediated myocardial ischaemia/reperfusion damage by upregulating GPX4 through activation of AMPK/GSK3β/Nrf2 signalling
Haoyang Lu, Hui Xiao, Manyu Dai, et al.
Pharmaceutical Biology (2021) Vol. 60, Iss. 1, pp. 38-45
Open Access | Times Cited: 63

Emerging roles of ferroptosis in cardiovascular diseases
Kai Wang, Xinzhe Chen, Yunhong Wang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 62

Xanthohumol Protects the Rat Myocardium against Ischemia/Reperfusion Injury-Induced Ferroptosis
Jianhong Lin, Kun‐Ta Yang, Wen‐Sen Lee, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 53

Resveratrol Attenuate Myocardial Injury by Inhibiting Ferroptosis Via Inducing KAT5/GPX4 in Myocardial Infarction
Jing Liu, Mingming Zhang, Chaoshi Qin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 51

Targeting ferroptosis: Paving new roads for drug design and discovery
Yilin Gu, Yizhe Li, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115015-115015
Closed Access | Times Cited: 51

Ferroptosis: A Potential Target in Cardiovascular Disease
Yanlong Leng, Xing Luo, Jiaying Yu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 42

Cardiomyocyte death in sepsis: Mechanisms and regulation (Review)
Geping Zhang, Dong Dan, Xianyao Wan, et al.
Molecular Medicine Reports (2022) Vol. 26, Iss. 2
Open Access | Times Cited: 41

Ferroptosis in organ ischemia–reperfusion injuries: recent advancements and strategies
Xiaoyu Luan, Peng Chen, Longyu Miao, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 11

Ferroptosis contributing to cardiomyocyte injury induced by silica nanoparticles via miR-125b-2-3p/HO-1 signaling
Xueyan Li, Hailin Xu, Xinying Zhao, et al.
Particle and Fibre Toxicology (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 9

Herbal medicines provide regulation against iron overload in cardiovascular diseases: Informing future applications
Jia Liu, Liangyan Deng, Liping Qu, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117941-117941
Closed Access | Times Cited: 8

Dexmedetomidine Inhibits Ferroptosis to Alleviate Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Regulating the HDAC2/FPN Pathway
Y. M. Fu, QingDong Wang, Wang Dong-wei, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access | Times Cited: 1

Inhibition of ferroptosis reduces susceptibility to frequent excessive alcohol consumption-induced atrial fibrillation
Chang Dai, Bin Kong, Tianyou Qin, et al.
Toxicology (2021) Vol. 465, pp. 153055-153055
Closed Access | Times Cited: 46

The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury
Л. Н. Маслов, С. В. Попов, N. V. Naryzhnaya, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 697-719
Closed Access | Times Cited: 34

Page 1 - Next Page

Scroll to top